Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection-Reference-Cited by-同舟云学术

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Published:2024-01 Issue: Volume:263 Page:115908
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Mei Shuang,Zou Yunting,Jiang Su,Xue Lu,Wang Yuting,Jing Han,Yang Peng,Niu Miao-Miao,Li Jindong,Yuan Kai,Zhang Yan^ORCID

Funder

Jiangsu Pharmaceutical Association

National Natural Science Foundation of China

Jiangsu Province Natural Science Foundation

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference59 articles.

1. A new coronavirus associated with human respiratory disease in China;Wu;Nature,2020

2. Weekly epidemiological update on COVID-19 - 10 August 2022. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---8-march-2023 (accessed 2023-March-13).

3. Inhibitors of SARS-CoV-2 entry: current and future opportunities;Xiu;J. Med. Chem.,2020

4. COVID-19 update: the race to therapeutic development;Twomey;Drug Resist. Updates,2020

5. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein;Walls;Cell,2020

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Substance P – a regulatory peptide with defense and repair functions. Results and perspectives for the fight against COVID-19;Frontiers in Neurology;2024-05-30

2. Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions;MedComm;2024-03-15